太平洋生物科学

US · PACB #3373 按市值排名

1.73 -0.23 -11.73%

实时 - 追踪5344个代码 - 心跳于235秒前 · 2026-10-16 19:56

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了1家。
机构持股总比例下降了2.1个百分点。

机构持股

机构持股比例: 60.78% -2.12pp
机构数量: 258 -1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund40.62%

Hedge Fund8.82%

Public Company8.06%

Private Company2.24%

Individual/Insider1.07%

VC/PE Fund0.54%

Insurance Company0.31%

Other38.18%

主要股东截至 2026-06-30

BlackRock 10.40% · 32.34M 股

ARK Investment Management LLC 9.58% · 29.78M 股

SoftBank Group Corp. 6.58% · 20.45M 股

Vanguard Capital Management, LLC 5.01% · 15.59M 股

Geode Capital Management, LLC 2.45% · 7.61M 股

Amova Asset Management 1.93% · 6.01M 股

State Street Global Advisors 1.92% · 5.96M 股

Point72 Asset Management, L.P. 1.54% · 4.79M 股

Two Sigma Investments, LP 1.36% · 4.24M 股

D. E. Shaw & Co., L.P. 1.35% · 4.21M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 38次买入 · 12次卖出

姓名	职务	持股比例
Christian O. Henry	Chief Executive Officer	0.40%
Mark Van Oene	Chief Operating Officer	0.33%
Kathy Ordonez	Independent Director	0.13%
James Gibson	Chief Financial Officer	0.05%
John Milligan	Independent Chairperson	0.04%
Marshall Mohr	Independent Director	0.04%
Michele Farmer	Vice President	0.03%
William Ericson	Independent Director	0.01%
Hannah Valantine	Independent Director	0.01%
Lucy Shapiro	Independent Director	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-08-16	Mark Van Oene	Chief Operating Officer	Open Market Disposition	-26,911	$1.13
2026-08-09	Mark Van Oene	Chief Operating Officer	Other Acquisition	+489,130	--
2026-08-09	Mark Van Oene	Chief Operating Officer	Other Derivative Acquisition	+1,967,888	$1.15
2026-06-02	William Ericson	Independent Director	Other Derivative Acquisition	+223,492	$1.58
2026-06-02	Kathy Ordonez	Independent Director	Other Derivative Acquisition	+223,492	$1.58
2026-06-02	John Milligan	Independent Chairperson	Other Derivative Acquisition	+223,492	$1.58
2026-06-02	Marshall Mohr	Independent Director	Other Derivative Acquisition	+223,492	$1.58
2026-06-02	Christopher Smith	Director	Other Derivative Acquisition	+223,492	$1.58
2026-06-02	Randall Livingston	Independent Director	Other Derivative Acquisition	+223,492	$1.58
2026-06-02	Christopher Gibson	Director	Other Derivative Acquisition	+74,497	$1.58
2026-06-02	Hannah Valantine	Independent Director	Other Derivative Acquisition	+223,492	$1.58
2026-04-07	Christopher Gibson	Director	Other Acquisition	+57,473	--
2026-04-07	Christopher Gibson	Director	Other Derivative Acquisition	+77,842	$1.52
2026-03-31	James Gibson	Chief Financial Officer	Open Market Disposition	-88,185	$1.37
2026-03-02	Christian O. Henry	Chief Executive Officer	Open Market Disposition	-12,497	$1.51
2026-03-02	Christopher Gibson	Director	Other Acquisition	+53,913	--
2026-03-02	Christopher Gibson	Director	Other Derivative Acquisition	+73,087	$1.52
2026-03-02	Mark Van Oene	Chief Operating Officer	Open Market Disposition	-6,504	$1.51
2026-03-02	Michele Farmer	Vice President	Open Market Disposition	-2,979	$1.51
2026-02-26	Christian O. Henry	Chief Executive Officer	Other Acquisition	+920,810	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:56:13 · 仅供参考，不构成投资建议，也未考虑您的具体情况。